Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-236222
Filing Date
2020-08-31
Accepted
2020-08-31 16:04:52
Documents
5
Period of Report
2020-10-08
Effectiveness Date
2020-08-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A d15066ddef14a.htm DEF 14A 401222
2 GRAPHIC g15066g10r12.jpg GRAPHIC 24294
3 GRAPHIC g15066g68d40.jpg GRAPHIC 7348
4 GRAPHIC g15066g82l95.jpg GRAPHIC 13033
5 GRAPHIC g15066sp001.jpg GRAPHIC 2957
  Complete submission text file 0001193125-20-236222.txt   468210
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: DEF 14A | Act: 34 | File No.: 000-17988 | Film No.: 201151615
SIC: 2835 In Vitro & In Vivo Diagnostic Substances